High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): Protocol of a phase II randomised controlled trial

Visalini Nair-Shalliker*, David P. Smith, Val Gebski, Manish I. Patel, Mark Frydenberg, John W. Yaxley, Robert Gardiner, David Espinoza, Michael G. Kimlin, Michael Fenech, David Gillatt, Henry Woo, Bruce K. Armstrong, Krishan Rasiah, Nader Awad, James Symons, Howard Gurney

*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

2 Citations (Scopus)
44 Downloads (Pure)

Fingerprint

Dive into the research topics of 'High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): Protocol of a phase II randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences